Shelley Berger | |
|---|---|
 Berger lectures for the National Institutes of Health in 2014 | |
| Alma mater | |
| Scientific career | |
| Institutions | |
Shelley L. Berger is the Daniel S. Och Professor of cell and developmental biology at the University of Pennsylvania School of Medicine. Her research focuses on epigenetics.
Berger graduated from the University of Michigan Ann Arbor with a BS in biology in 1982 and a PhD in cell and molecular biology in 1987. [1] She did a postdoctoral fellowship at MIT. Prior to joining the University of Pennsylvania faculty, she was the Hilary Koprowski Professor at the Wistar Institute in Philadelphia. [2]
The Perelman School of Medicine, commonly known as Penn Med, is the medical school of the University of Pennsylvania, a private research university in Philadelphia, Pennsylvania. Founded in 1765, the Perelman School of Medicine is the oldest medical school in the United States and one of the seven Ivy League medical schools.
Brigid L. M. Hogan FRS is a developmental biologist noted for her contributions to mammalian development, stem cell research and transgenic technology and techniques. She is currently a Professor in the Department of Cell Biology at Duke University, Born in the UK, she became an American citizen in 2000.
Diane Edmund Griffin is the university distinguished professor and a professor in the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, where she was the department chair from 1994-2015. She is also the current vice-president of the National Academy of Sciences. She holds joint appointments in the departments of Neurology and Medicine. In 2004, Griffin was elected to the United States National Academy of Sciences (NAS) in the discipline of microbial biology.
Aviv Regev is a computational biologist and systems biologist and Executive Vice President and Head of Genentech Research and Early Development in Genentech/Roche. She is a core member at the Broad Institute of MIT and Harvard and professor at the Department of Biology of the Massachusetts Institute of Technology. Regev is a pioneer of single cell genomics and of computational and systems biology of gene regulatory circuits. She founded and leads the Human Cell Atlas project, together with Sarah Teichmann.
Clara Franzini-Armstrong is an Italian-born American electron microscopist, and Professor Emeritus of Cell and Developmental Biology at University of Pennsylvania.
Lucy Shapiro is an American developmental biologist. She is a professor of Developmental Biology at the Stanford University School of Medicine. She is the Virginia and D.K. Ludwig Professor of Cancer Research and the director of the Beckman Center for Molecular and Genetic Medicine.
Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well known for his research on T cell therapies for the treatment of several forms of cancers. In 2020 he was elected to the American Philosophical Society.
Professor Carol L. Prives FRS is the Da Costa Professor of Biological Sciences at Columbia University. She is known for her work in the characterisation of p53, an important tumor suppressor protein frequently mutated in cancer.
Susan Margulies is an American engineer and assistant director of the U.S. National Science Foundation, heading the Directorate for Engineering. She is also the Georgia Research Alliance Eminent Scholar in Injury Biomechanics and Professor in the Wallace H. Coulter Department of Biomedical Engineering at the Georgia Institute of Technology and Emory University, where she served as chair from 2017 to 2021. She is a world leader in the biomechanics of head injury in infants.
Jeffrey Drebin is a surgeon and scientist. He serves as the Department of Surgery Chair at Memorial Sloan Kettering.
Donald M. O'Rourke is an American neurosurgeon and the John Templeton, Jr., MD Professor of Neurosurgery at the Perelman School of Medicine at the University of Pennsylvania. He graduated from Harvard University with an A.B. in Biochemistry and Molecular Biology in 1983, and attended medical school at the University of Pennsylvania where he also completed neurosurgical residency training. He established the institution's human brain tumor tissue bank in 2001. An elected member of the American Academy of Neurological Surgery, his research at the Translational Center of Excellence in the Abramson Cancer Center focuses on Glioblastoma Multiforme, especially the design and investigation of Chimeric Antigen Receptor immune therapies.
David H. Raulet is an immunologist who specializes in studying the role of natural killer cells. He is a professor in the Department of Molecular and Cell Biology at the University of California, Berkeley where he also holds the Esther and Wendy Schekman Chair in cancer biology. He was elected to the National Academy of Sciences in 2019. Raulet is also the co-founder of Dragonfly Therapeutics, a company that seeks to use natural killer cells for cancer immunotherapy.
Marie Celeste Simon is the Arthur H. Rubenstein Professor of cell and developmental biology, the scientific director of the Abramson Family Cancer Research Institute, and the associate director of the Abramson Cancer Center Core Facilities, at the University of Pennsylvania Perelman School of Medicine. Her research focuses on cancer cell metabolism, angiogenesis, and immunology.
Donita C. Brady is a cancer biologist and the Presidential Assistant Professor of Cancer Biology at the Perelman School of Medicine at the University of Pennsylvania. Her research examines how cells communicate through kinases and nutrient homeostasis, and in particular, the central role of copper and other metals in these interactions.
Kathleen J. Green is a cell biologist whose research focuses on how cell-cell communication drives tissue form and function. She is the Joseph L. Mayberry Professor of Pathology and Toxicology and Professor of Dermatology at Northwestern University Feinberg School of Medicine in Chicago. She also serves as Associate Director of Basic Sciences at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Marisa Bartolomei is an American cell biologist, the Perelman Professor of Cell and Developmental Biology and Co-Director of the Epigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania. Her research considers epigenetic processes including genomic imprinting. She was elected to the National Academy of Sciences in 2021.
Deborah Anne Driscoll is an American reproductive geneticist. She is the Luigi Mastroianni Jr. Professor and chair of the Department of Obstetrics and Gynecology at the Perelman School of Medicine at the University of Pennsylvania.
Chi Van Dang is a hematological oncologist and researcher, currently serving as the Scientific Director of Ludwig Institute for Cancer Research. He is known for his research on genetics, the MYC gene and the cellular energy metabolism of cancer.
Raquel E. Gur is an American psychiatrist known for her research on schizophrenia. She is Professor of Psychiatry, Neurology, and Radiology at the University of Pennsylvania Perelman School of Medicine. She has been a faculty member of the University of Pennsylvania's Department of Psychiatry since 1975, and serves as Karl and Linda Rickels Professor of Psychiatry and Vice Chair of Research Development within this department. She has served as president of both the Society of Biological Psychiatry and the American College of Neuropsychopharmacology. She was elected as a fellow of the American College of Neuropsychopharmacology in 2000 and to the National Academy of Medicine in 2001. In 2011, she received the William C. Menninger Memorial Award from the American College of Physicians.
Guo-li Ming is a Chinese-American neuroscientist. She is the Perelman Professor of Neuroscience and a member of the Institute of Regenerative Medicine at the University of Pennsylvania. In 2019, Ming was elected to the National Academy of Medicine for "pioneering the use of patient-derived human stem cells to model genetic and environmental risk for brain disorders, which has transformed our understanding of underlying mechanisms and potential therapeutic strategies."
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
